We understand that you might be feeling anxious in view of the recent developments. We would like to clarify some of the key issues which are particularly relevant for you as a patient at the Bern Biel Breast Centre.

Am I in a group of people who are particularly at risk (subsequently referred to as a “vulnerable group”)?

  • I have had breast cancer. However, I am feeling healthy now and my aftercare has recently been progressing normally.
    You are not in a vulnerable group.
    Women do not contract infectious diseases more frequently after breast cancer. You are now just as healthy as anyone else and should be feeling that way.
  • I have had chemotherapy in the past.
    You are not in a vulnerable group.
    Your immune system was only compromised for a short period by the chemotherapy. You can generally assume that once your white blood cells (leukocytes) have recovered, your immune defences will be functioning normally.
  • I am taking antihormone medication, or have taken it in the past (such as tamoxifen, anastrozole e.g. Arimidex®, letrozole e.g. Femara®, exemestane e.g. Aromasin®).
    You are not in a vulnerable group.
    Women are not at any additional risk whatsoever during or after antihormone therapy.
  • I have completed my course of chemotherapy and am receiving intravenous antibody treatment (e.g. Herceptin® or Perjeta®).
    You are not in a vulnerable group, provided that your blood count has recovered from the chemotherapy.
  • You are in a vulnerable group if...
    a) …you are currently receiving chemotherapy.
    b) …you are taking CDK4/6 inhibitors (palbociclib = Ibrance®, ribociclib = Kisqali®, abemaciclib).
    c) …you have diseases at an advanced stage requiring long-term treatment (e.g. everolimus, alpelisib, cortisone preparations)
    If you are a patient in a vulnerable group, please discuss how to proceed during your oncological consultation.

Weitere Informationen finden Sie auf der Website der Krebsliga.